ArticleBMC cancer2022

Antitumor activity of the protein kinase inhibitor 1-(β-D-2'-deoxyribofuranosyl)-4,5,6,7-tetrabromo- 1H-benzimidazole in breast cancer cell lines.

Mirosława Koronkiewicz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.